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Fisch et al. find that GBP1 targets
Toxoplasma vacuolar and parasite
membranes for disruption of both
membranes. In contrast, appearance of
cytosolic Salmonella is GBP1
independent, but caspase-4 recruitment
to bacteria and activation is GBP1
dependent. In a negative feedback loop,
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https://doi.org/10.1016/j.celrep.2020.108008SUMMARYInterferon-inducible guanylate-binding proteins (GBPs) promote cell-intrinsic defense through host cell
death. GBPs target pathogens and pathogen-containing vacuoles and promote membrane disruption for
release of microbial molecules that activate inflammasomes. GBP1 mediates pyroptosis or atypical
apoptosis of Salmonella Typhimurium (STm)- or Toxoplasma gondii (Tg)- infected human macrophages,
respectively. The pathogen-proximal detection-mechanisms of GBP1 remain poorly understood, as humans
lack functional immunity-related GTPases (IRGs) that assist murine Gbps. Here, we establish that GBP1 pro-
motes the lysis of Tg-containing vacuoles and parasite plasma membranes, releasing Tg-DNA. In contrast,
we showGBP1 targets cytosolic STm and recruits caspase-4 to the bacterial surface for its activation by lipo-
polysaccharide (LPS), but does not contribute to bacterial vacuole escape. Caspase-1 cleaves and inacti-
vates GBP1, and a cleavage-deficient GBP1D192E mutant increases caspase-4-driven pyroptosis due to
the absence of feedback inhibition. Our studies elucidate microbe-specific roles of GBP1 in infection detec-
tion and its triggering of the assembly of divergent caspase signaling platforms.INTRODUCTION
Most nucleated cells can defend themselves against infection by
viruses, bacteria, and eukaryotic parasites in a process called
cell-intrinsic immunity. These defense programs respond to the
detection of pathogens by membrane-bound or cytosolic
pattern recognition receptors (PRRs) (Jorgensen et al., 2017;
MacMicking, 2012; Mostowy and Shenoy, 2015; Randow
et al., 2013). In addition to antimicrobial molecules that restrict
or kill pathogens, host cell-death is a destructive yet effective
mechanism of defense since it removes replicative niches and
traps intracellular pathogens within cell remnants (Jorgensen
et al., 2016). Antimicrobial immunity and cell death are enhanced
by the type-II interferon (IFNg), which induces the expression of
up to 2,000 IFN-stimulated genes (ISGs) (MacMicking, 2012;
Schoggins, 2019). The guanylate-binding protein (GBP) family
of GTPases, which are highly abundant in cells exposed to
IFNg, consists of seven members in the humans and eleven
members in mice (Kresse et al., 2008; Olszewski et al., 2006;This is an open access article under the CC BY-NShenoy et al., 2007, 2012). GBPs target intracellular pathogens
and mediate host-defense via autophagy, oxidative responses,
inflammasomes, and cell death (Costa Franco et al., 2018;
Feeley et al., 2017; Foltz et al., 2017; Gomes et al., 2019; Haldar
et al., 2013, 2014, 2015; Kim et al., 2011, 2012; Li et al., 2017; Lin-
denberg et al., 2017; Liu et al., 2018;Man et al., 2015, 2017;Meu-
nier et al., 2014, 2015; Piro et al., 2017; Santos et al., 2018; She-
noy et al., 2012; Tripal et al., 2007; Wallet et al., 2017; Wandel
et al., 2017; Zwack et al., 2017).
Once GBPs translocate to a pathogen vacuole or the path-
ogen itself, they are thought to disrupt these membranes by
an as yet uncharacterized mechanism (Kravets et al., 2016;
Meunier et al., 2014; Selleck et al., 2013; Yamamoto et al.,
2012). Disruption of barrier membranes leads to pathogen
growth control and release of pathogen-associated molecular
patterns (PAMPs), which are sensed by PRRs that can trigger
host cell death. Whether GBPs directly recognize pathogen
vacuolar membranes or PAMPs is an important question that




OPEN ACCESSet al., 2018; Meunier et al., 2014; Pilla et al., 2014; Santos et al.,
2018).
A large body of work on GBPs has been carried out in murine
cells, wherein these proteins closely collaborate with members of
asecondfamilyof IFN-inducedGTPases,comprising23members,
the p47 immunity-related GTPases (IRGs) (Haldar et al., 2014;
Hunn et al., 2008; Khaminets et al., 2010; Miyairi et al., 2007; She-
noy et al., 2007; Singh et al., 2006, 2010; Tiwari et al., 2009). For
instance, mouse Irgb10 targets bacteria following mGbp recruit-
ment and contributes to the release of bacterial LPS and DNA,
andmouse Irgm1 and Irgm3 are essential regulators of mGbp-tar-
geting of some pathogen-containing vacuoles (Haldar et al., 2015;
Man et al., 2016;Meunier et al., 2014; Singh et al., 2010). However,
onlyoneconstitutivelyexpressed, truncated IRG,called ‘‘IRGM,’’ is
present in the human genome (Bekpen et al., 2005, 2010). There-
fore, how human GBPs target intracellular pathogens remains un-
known. In addition, somePRRsare unique to humans, for example
caspase-4 and caspase-5 (Casson et al., 2015; Ding and Shao,
2017;Kayagaki etal., 2011,2013;Shi etal., 2014),whichenablehu-
man, but not mouse cells, to respond to tetra-acylated LPS (La-
grange et al., 2018). The mechanisms underlying GBP-mediated
detection of pathogens and stimulation of human macrophage
death therefore need to be investigated further.
All seven human GBPs have a conserved structure with an
N-terminal globular GTPase domain and a C-terminal helical
domain. GBP1, GBP2, and GBP5 can be isoprenylated at their
C-terminal CaaX-box, allowing membrane anchoring (Britzen-
Laurent et al., 2010; Nantais et al., 1996; Olszewski et al.,
2006; Tripal et al., 2007). Differences in pathogen-targeting
have been noted depending on the pathogen and cell type. We
previously showed that human GBP1 fails to target the apicom-
plexan parasite Toxoplasma gondii (Tg) and two intracellular
bacterial pathogens, Chlamydia trachomatis and Salmonella en-
terica subsp. enterica serovar Typhimurium (STm), in human
A549 epithelial cells; however, GBP1 is required for the restric-
tion of parasite growth, but not the bacterial pathogens (John-
ston et al., 2016). On the other hand, in human macrophages
GBP1 localizes to Tg, Chlamydia, and STm, but whether it can
disrupt membranes that enclose these pathogens is not known
(Al-Zeer et al., 2013; Fisch et al., 2019a).
During Tg or STm infection-induced death of human macro-
phages, GBP1 targeting to pathogens is necessary, even though
downstream mechanisms of cell death are distinct. Since Tg in-
duces the loss of several inflammasome proteins, including
NLRP3 (NOD, leucine rich repeat and pyrin domain containing
protein 3) and caspase-1, human macrophages undergo atypical
apoptosis through the assembly of AIM2 (absent in melanoma 2)
-ASC (apoptotic-associated speck-like protein with a CARD)-cas-
pase-8 complexes. In contrast, GBP1 promotes activation of cas-
pase-4 following its recruitment to STm, resulting in enhanced py-
roptosis (Fisch et al., 2019a). Although our previous work
suggested that GBP1 is involved in PAMP release for detection
by these PRRs during natural infection, the underlying mecha-
nisms involved in liberatingmicrobial ligands was not investigated
(Fisch et al., 2019a). In this study we show that GBP1 contributes
to the lysis of parasite-containing vacuoles and the plasmamem-
brane of Tg by employing two assays. We also show that GBP1
exclusively targets STm that are already cytosolic and does not2 Cell Reports 32, 108008, August 11, 2020contribute to their ability to reach the cytosol of human macro-
phages. In contrast, during STm infection, caspase-1 cleaves
and inactivates GBP1, and thereby reduces its ability to recruit
caspase-4. These studies reveal the feedback inhibition of
GBP1-caspase-4-driven pyroptosis during STm infection and its
dual membrane-disruptive actions during Tg infection.
RESULTS
GBP1 Contributes to Toxoplasma Parasite and Vacuole
Disruption and Infection Control
As GBP1 elicits divergent host cell death programs in response to
TgandSTm,wesought to investigate theupstreammechanismsof
GBP1 during infection by these two unrelated pathogens. We pre-
viously correlated GBP1 recruitment to Tg parasitophorous vacu-
oles (PVs) to the activation of AIM2-caspase-8 and recognition of
parasite DNA (Fisch et al., 2019a). We hypothesized that, like
somemurineGbps (Degrandi et al., 2013; Kravets et al., 2016; Sell-
eck et al., 2013; Yamamoto et al., 2012), human GBP1 promotes
PV opening and cytosolic access to intravacuolar pathogens.
Extending our previous finding of GBP1 recruiting to the PV,
we also localized GBP1 directly to the surface of Tg using Airy-
Scan super-resolution microscopy (Figure 1A). To test whether
GBP1 can disrupt Tg PVs, we used the cytosolic dye CellMask,
which is excluded from PVs but enters once the PV membrane
(PVM) is disrupted (Figure 1B). As positive control for this assay,
PVs were chemically disrupted by detergent-mediated permea-
bilization, resulting in higher fluorescence within the vacuoles as
compared to untreated cells (Figure 1B). IncreasedCellMask dye
intensity within naturally disrupted PVs could be reliably quanti-
fied using our artificial intelligence-based high-throughput image
analysis workflowHRMAn (Fisch et al., 2019b), which enabled us
to enumerate dye access within thousands of PVs upon infection
of type-I and type-II Tg strains. Analysis of CellMask fluores-
cence within PVs in IFNg-primed THP-1 wild-type (WT) cells re-
vealed increased intensities, indicating their disruption (Fig-
ure S1A). However, analysis of IFNg-primed THP-1 DGBP1
cells showed that Tg vacuoles were not disrupted, as seen by
the exclusion of CellMask dye (Figure S1A). Doxycycline (Dox)
induced re-expression of GBP1 (THP-1DGBP1+Tet-GBP1 cells)
rescued vacuole breakage; as controls, empty-vector trans-
duced cells (THP-1 DGBP1+Tet-EV) behaved like DGBP1 cells
(Figure S1A). We next used Dox-induced expression of
mCherry-GBP1 (THP-1 DGBP1+Tet-mCH-GBP1 cells) to allow
quantification of GBP1-recruitment to Tg and stratify data on
whether PVs that were decorated with mCH-GBP1 lost their
integrity. Indeed, a population of GBP1+ PVs was unable to
exclude CellMask dye, clearly indicating loss of membrane
integrity (Figure 1C). Taken together, we concluded that GBP1
contributes to the opening of PVs, and GBP1-targeted vacuoles
preferentially undergo loss of membrane integrity.
Similar to our finding of GBP1 recruitment directly to the para-
site surface, presumably within broken vacuoles, previous work
localized murine Gbps directly onto the surface of the Tg plasma
membrane (Kravets et al., 2016). Whether direct recruitment of a
GBP to a Tg parasite leads to disruption of the parasite plasma
membrane has not been studied. We developed a second assay






Figure 1. GBP1 Disrupts Toxoplasma Vacuoles and Parasite Membrane
(A) AiryScan immunofluorescence images of type I or type II Toxoplasma gondii (Tg) decorated with mCH-GBP1 in IFNg- and Doxycycline (Dox)-treated THP-1
DGBP1+Tet-mCH-GBP1 cells. Red: mCH-GBP1; white: Tg. White arrowhead indicates GBP1 on the parasite; yellow arrowhead indicates GBP1 on the vacuole
membrane. Scale bar, 4 mm.
(B) Left: illustration of the high-throughput imaging assay to measure parasitophorous vacuole (PV) integrity by CellMask flooding. Right: representative
immunofluorescence images from proof-of-principle experiment using THP-1WT infected with type I Tg for 18 h and stained with CellMask but not permeabilized
(no perm.; top) or fully permeabilized with saponin (full perm.; bottom) and corresponding rainbow intensity diagram to illustrate the CellMask signal from images
used for quantification; AU: arbitrary units for fluorescence intensity values. Red: CellMask; gray: Tg; blue: nuclei. Scale bars, 10 mm.
(C) Representative quantification of CellMask fluorescence intensities within vacuoles (PV) of type I or type II Tg infected THP-1 DGBP1+Tet-mCH-GBP1 pre-
treated with IFNg and Dox to induce GBP1 expression. Plotted depending on whether PVs were decorated with GBP1 (+) or not (). N = number of vacuoles.
(D) Illustration of the high-throughput imaging assays to measure Tg integrity with the split-GFP system.
(E and F) Example immunofluorescence image (E) and quantification (F) of disrupted and thus green-fluorescing type II Tg parasites expressing GFP1-10 fragment
(Pru DHpt+GFP1-10) infecting IFNg-primed THP-1+GFP11 or IFNg and Dox-primed THP-1 DGBP1+Tet-GBP1+GFP11 cells stained for all Tg using anti-surface-
antigen 1 (SAG1). Data plotted as proportion of all parasites (left), proportion of all PVs containing at least one green parasite (middle), or proportion of green
parasites within the same PV (right). Red: SAG1; green: holo-GFP; blue: nuclei. Scale bar, 20 mm.
Graphs in (F) show mean ± SEM from n = 3 independent experiments. Graphs in (C) representative of n = 3 independent experiments. ***p % 0.001 or ****p %
0.0001 in (C) from nested Student’s t test comparing GBP1+ to GBP1 objects from the three experiments following adjustment for multiple comparisons and in
(F) from two-way ANOVA comparing to untreated (UT) condition.
See also Figures S1 and S2.
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OPEN ACCESSGFP complementation approach, Tg parasites only fluoresce
upon access of a GFP11 fragment expressed in the host-cell
cytosol (Figure S1B) to the GFP1-10 fragment expressed in the
Tg cytosol (Figure S1C); neither fragment is fluorescent on its
own (Romei and Boxer, 2019). If the PV and the Tg membranes
are both disrupted, the fragments can assemble to form fluores-
cent GFP holo-protein (Figure 1D). Indeed, we could observe
GFP-fluorescing parasites in IFNg-primed THP-1+GFP11 cells
(Figure 1E) and quantify the proportion of parasites with GFP fluo-
rescence (Figure 1F). Tg only becamedisrupted in the presence of
GBP1 and all parasites within the same vacuole were disrupted,
suggesting that once PV integrity is lost, the Tgs within them are
susceptible to membrane damage (Figure 1F). Imaging results
were confirmed using flow cytometry analysis of Tg from infected
THP-1 cells (Figure S1D). Plaque assay of sorted parasites
confirmed that green-fluorescing Tg were not viable (Figure S1E).We validated our PV disruption assays by examining the ultra-
structure of the vacuole membranes using correlative light and
electron microscopy, which revealed ruffled and broken vacuole
membranes in cells expressing GBP1 (Figure S2). In THP-1
DGBP1, most PVs analyzed by electron microscopy did not
show structural defects or loss ofmembrane integrity (Figure S2).
Together, our assays indicated that GBP1 contributes to the
disruption of both the PV membrane and the Tg plasma
membrane.
GBP1 Does Not Participate in Salmonella Vacuolar
Escape but Targets Cytosolic Bacteria
Having established an indispensable role for GBP1 in disrupting
TgPVs and parasites, wewanted to test if GBP1 also contributed
to the escape of STm from Salmonella-containing vacuoles
(SCVs). In murine cells, Gbps have been found to disrupt SCVsCell Reports 32, 108008, August 11, 2020 3
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Figure 2. GBP1 Only Targets Already Cytosolic Salmonella and Recruits Caspase-4
(A) Representative immunofluorescence images at 2 h p.i. and quantification of the proportion of cytosolic Salmonella Typhimurium (STm) from differentially
permeabilized, IFNg-primed THP-1 WT or DGBP1 cells infected with STm SL1344 (MOI = 30) at indicated time p.i. Cells are outlined by the white, dashed line.
Gray: STm; green: pseudo-colored cytosolic and extracellular STm; blue: nuclei. Scale bar, 10 mm.
(B) Representative immunofluorescence images at 2 h p.i., and quantification of GBP1 recruitment to cytosolic and intra-vacuolar STm in IFNg-primed and Dox-
treated THP-1 DGBP1+Tet-mCH-GBP1, infected with STm SL1344 (MOI = 30) at indicated times p.i. from differentially permeabilized cells stained for cytosolic
STm and total STm. Cells are outlined by the white, dashed line. Red: mCH-GBP1; gray: STm; green: cytosolic STm; blue: nuclei. Scale bar, 10 mm.
(C) Quantification of galectin-8 (Gal-8) recruitment to STm SL1344-GFP in IFNg-treated THP-1 WT or DGBP1 at the indicated times post infection.
(D) Representative immunofluorescence images at 1 h and quantification of Gal-8 recruitment to STm in IFNg- and Dox-treated THP-1 DGBP1+Tet-mCH-GBP1
infected with STm SL1344-GFP (MOI = 30) at the indicated time post infection. Red: mCH-GBP1; gray: STm; green: Gal-8; blue: nuclei. Scale bar, 10 mm.
(E) Representative quantification of CellMask fluorescence intensities surrounding STm in infected THP-1 DGBP1+Tet-mCH-GBP1 pre-treated with IFNg and
Dox to induce GBP1 expression at 4 h p.i. plotted depending on whether STm were decorated with GBP1 (+) or not (). N = number of STm quantified.
(F) Fold-change of intracellular STm colony forming units (CFUs) at 18 h p.i. normalized to 2 h p.i. of IFNg-primed THP-1 WT or DGBP1 cells measured using
gentamicin infection-protection assays.
Graphs in (A), (B) (C), (D), and (F) showmean ± SEM from n = 3 independent experiments and in (E) representative of n = 2 experiments. *p% 0.05 or ***p% 0.001
in (E) from nested Student’s t test comparing GBP1+ to GBP1 objects from the two experiments following adjustment for multiple comparisons and in (A), (C),
and (F) from two-way ANOVA following adjustment for multiple comparisons; ns, not significant.
See also Figure S3.
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OPEN ACCESSas well as directly recognize bacterial LPS in the cytoplasm
(Meunier et al., 2014; Pilla et al., 2014). We used differential per-
meabilization (Meunier and Broz, 2015; Meunier et al., 2014) to
determine whether the escape of STm from its vacuole into the
cytosol required GBP1. Similar numbers of cytosolic bacteria
were detected in WT and DGBP1 cells, suggesting that GBP1
is dispensable for vacuole escape of STm (Figure 2A) and indi-
cating a microbe-specific role for GBP1 in disruption of path-
ogen compartments. Importantly, differential permeabilization
revealed that GBP1 was exclusively recruited to cytosolic STm
at all time points (Figure 2B). Therefore, as a second independent
assay to analyze the ability of GBP1 to open STm vacuoles, we
used galectin-8 (Gal-8) as a marker for cytosolic bacteria, which
is recruited to disrupted SCVs in human epithelial cells, and pro-
motes bacterial xenophagy and growth-restriction (Thurston
et al., 2012). Consistent with the previously observed lack of a
role for GBP1 in cytosolic escape of STm, similar proportions4 Cell Reports 32, 108008, August 11, 2020of STm were decorated with Gal-8 in WT and DGBP1 cells (Fig-
ure 2C). Temporal studies showed that SCVs were rapidly dis-
rupted (became Gal-8+), but lost this marker over time (Fig-
ure 2C), as has been shown before in epithelial cells (Thurston
et al., 2012). At later time points as the proportion of Gal-8+ vac-
uoles decreased, cytosolic STm retained GBP1 coating (Fig-
ure 2D). These single-cell assays revealed that unlike during Tg
infection, GBP1 does not contribute to vacuole escape of
STm, but recruits directly to cytosolic STm. We next used our
CellMask dye influx assay and measured fluorescence in the vi-
cinity of intracellular STm to determine if bacteria were vacuolar
or in broken vacuoles/cytosolic (Figure S3A). Consistent with
previous results, the assay confirmed that bacterial vacuole
escape was similar in WT or DGBP1+Tet-GBP1 macrophages
left untreated, treated with IFNg, or treated with IFNg+Dox (Fig-
ure S3B). Similarly, cytosolic STm that were decorated with





Figure 3. GBP1 Mediates Access to PAMPs During Toxoplasma and Salmonella Infection
(A) Left: representative immunofluorescence image of type I Tg grown in human foreskin fibroblasts (HFF WTs) in the presence of EdU DNA label. Labeled type I
Tg were harvested from the HFFs and used to infect (inf.) THP-1 DGBP1+Tet-mCH-GBP1 or THP-1 +myc-AIM2 for 6 h. THP-1 cells were pre-treated with IFNg
and Dox to induce mCH-GBP1 expression Middle: parasite DNA released into the cytoplasm was visualized by click-chemistry to label the incorporated EdU.
(legend continued on next page)






OPEN ACCESSvicinity as compared to vacuolar STm that had not been targeted
by GBP1 (Figure 2E). To assess the impact of GBP1 targeting on
bacterial replication, we performed gentamicin-protection as-
says. IFNg-treatment reduced bacterial replication by 70%
(Figure 2F). This remarkable restriction of STm, however, was
lost in DGBP1 cells (Figure 2F). Altogether, these results estab-
lished that GBP1 does not contribute to STm vacuole escape;
it targets cytosolic bacteria and reduces bacterial survival in
macrophages.
GBP1 Promotes Access to PAMPs for Cytosolic Host
Defense and Interacts with Caspase-4 on the Surface of
Salmonella
As Tg infection activates the DNA sensor AIM2 and we demon-
strated that GBP1 promotes PV and Tg plasma membrane
disruption, we wanted to visualize release of Tg-DNA into the
cytoplasm of infectedmacrophages and subsequent recognition
by AIM2. To this end, we labeled Tg-DNAs with EdU (5-ethynyl-
20-deoxyuridine) by growing them in human foreskin fibroblasts
(HFFs), whose DNA remains unlabeled as they do not replicate
due to contact-dependent growth inhibition. Following infection
of macrophages with EdU-labeled Tg, we visualized Tg-DNA
with Alexa Fluor 647 dye using click-chemistry and quantified
macrophages containing cytosolic Tg-DNA (Figure 3A). Approx-
imately 35% of infected macrophages that had at least one PV
targeted by GBP1 (GBP1+) contained Tg-DNA in their cytosol at
6 h p.i. while uninfected macrophages or infected macrophages
without targeted PVs did not show this phenotype (Figure 3A).
Furthermore, infection of myc-AIM2-expressing THP-1 macro-
phages showed the association of the AIM2 receptor with EdU-
labeled Tg-DNA in the cytosol (Figure 3A). Taken together, these
results corroborated the model that human GBP1 actively rup-
tures the Tg PV and parasites and releases Tg-DNA into the
cytosol for downstream detection by AIM2.
GBP1 thus promotes the sensing of PAMPs and formation of
cytosolic signaling platforms also known as supramolecular
organizing centers (SMOCs) (Kagan et al., 2014). We investi-
gated the structure of caspase activation SMOCs promoted by
GBP1 actions using structured illumination microscopy (SIM).
Upon Tg infection, AIM2 detects Tg-DNA and nucleates the for-
mation of an inflammasome containing ASC and caspase-8. Us-Right: quantification of proportion of infected cells with cytosolic Tg-DNA based
Red: mCH-GBP1 or immune-stained myc-AIM2; white: EdU-DNA; green: Tg; blue
Tg-DNA indicated by yellow arrowheads. Scale bar, 10 mm.
(B and C) Representative immunofluorescence images (B) and quantification (C) o
mCH-GBP1+YFP-CASP4C258S cells infected with STm SL1344 (MOI = 30) for 2 h
bar, 10 mm. Contrast enhanced in the nuclei inset, to visualize STm-DNA used fo
(D) Representative immunofluorescence images at 1 h p.i. and quantification of
treated THP-1 DGBP1+Tet-mCH-GBP1+YFP-CASP4C258S infected with STm SL
YFP-caspase-4; blue: nuclei. Scale bar, 10 mm.
(E) Left: silver stain of SDS-PAGE gel showing immunoprecipitation (IP) of FLAG
infected with STm for 2 h, left UT. Right: volcano plot of mass spectrometry hits co
Welch difference of mass spectrometry intensities versus log10(p). Significant h
(F) Representative immunoblots of IP of endogenousGBP1 from IFNg-primed or n
of endogenous caspase-4 identified as a hit using mass spectrometry and no st
Graphs in (A) and (D) showmean ±SEM from n = 3 independent experiments. Grap
0.0001 in (C) from nested one-way ANOVA comparing to undecorated vacuoles
See also Figure S4 and Data S1.
6 Cell Reports 32, 108008, August 11, 2020ing SIM, we found that these atypical inflammasome complexes
appear similar to previously described inflammasomes contain-
ing ASC and caspase-1 or caspase-8 (Man et al., 2013, 2014).
We found a ‘‘donut’’-like ASC ring enclosing caspase-8 in the
center (Figures S4A and S4B). As we could not detect endoge-
nous AIM2 by immunofluorescence microscopy, we resorted
to using THP-1 cells expressing myc-AIM2 (Figure S4C), which
revealed AIM2 recruitment to ASC specks in Tg-infected macro-
phages (Figures S4D and S4E). Altogether, these studies confirm
that Tg-DNA is present within themacrophage cytosol as a result
of GBP1-mediated disruption of the PVM and Tg membrane re-
sulting in AIM2 activation.
We next decided to contrast GBP1 actions during STm infec-
tion, where we previously showed that caspase-4 is targeted
exclusively to GBP1+ STm (Fisch et al., 2019a). The question
was whether there is an interaction between GBP1 and cas-
pase-4, which leads to recruitment of the LPS-sensor, and
whether caspase-4 is recruited directly onto the surface of STm.
Indeed, 3D-rendered SIM imaging demonstrated GBP1 recruited
caspase-4 directly to the surface of cytosolic STm (Figure S4F).
Bacteria were completely covered in GBP1, with a high degree
of colocalizationwithYFP-CASP4C258S (FigureS4F). Interestingly,
immunofluorescence staining of Salmonella-LPS using a mono-
clonal antibody revealed that GBP1+-CASP4+ bacteria stained
either not at all or poorly, suggesting access to the epitope was
blocked (Figures 3B and 3C). STm that were undecorated or
CASP4–-GBP1+, however, were stained with anti-LPS antibody
(Figure 3B). As caspase-4 can directly bind LPS through its
CARD (Shiet al., 2014); thisfinding isconsistentwith thepossibility
that caspase-4 on thebacterial surfaceprecludes antibody-medi-
ated staining of LPS (Figure 3C). In addition, the monoclonal anti-
LPS antibody stained bacteria in THP-1 DCASP4 cells (Fig-
ure S4G), pointing toward epitope occlusion by caspase-4.
In further agreement with targeting of cytosolic bacteria, the
majority of Gal-8+-GBP1+ STm were also positive for caspase-
4. Notably, GBP1 and caspase-4 were retained on STm over
time even though Gal-8 staining had reduced (Figure 3D), which
suggested that GBP1-caspase-4 are present on cytosolic STm
longer during infection.
Our previous work showed that the translocation of GBP1 to
STm and enhanced pyroptosis requires its GTPase functiongrouped based on whether the cells contain a GBP1-targeted (GBP1+) Tg PV.
: nuclei. Some released, cytosolic (and additionally AIM2-bound, lower panels)
f LPS staining intensity of STm from IFNg and Dox-treated THP-1 DGBP1+Tet-
. Red: mCH-GBP1; gray: STm-LPS; green: YFP-caspase-4; blue: nuclei. Scale
r detection of bacteria that do not stain for LPS.
Gal-8 and caspase-4 (CASP4) recruitment to STm in IFNg-primed and Dox-
1344 (MOI = 30) at indicated times p.i. Red: mCH-GBP1; gray: Gal-8; green:
-GBP1 from THP-1 DGBP1+Tet-FLAG-GBP1 treated with IFNg and Dox and
mparing IFNg treated cells with IFNg treated and STm-infected cells. Plotted as
its shown in orange/red circles.
aive THP-1WT infectedwith STm for 2 h as indicated, showing co-precipitation
able interaction with caspase-1.
h in (C) representative of n = 3 independent experiments. *p% 0.05 and ****p%
for the means of the n = 3 independent experiments; ns, not significant.
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whether these functions contributed to caspase-4 targeting to
STm. THP-1 DGBP1 cells reconstituted with Dox-inducible var-
iants of GBP1 that lacked GTPase activity (GBP1K51A) or isopre-
nylation sites (GBP1C589A or GBP1D589-592; Figure S4H) revealed
that none of these variants supported the recruitment of cas-
pase-4 (Figures S4I and S4J). Taken together, through single-
cell comparative analyses we established that GBP1-targeting
to Tg promotes the release of parasite DNA into the cytosol,
whereas GBP1-targeting to STm enables caspase-4 recruitment
to cytosolic bacteria. The reduced LPS staining on bacteria
further suggest that GBP1 facilitates access of bacterial LPS
ligand to caspase-4.
We additionally decided to use an unbiased proteomics
approach to identify GBP1 binding-partners and other proteins
recruited to GBP1-caspase-4 SMOCs on cytosolic STm. For
this, we immunoprecipitated Dox-inducible FLAG-GBP1 from
STm-infected THP-1 DGBP1+Tet-FLAG-GBP1 cells following
protein cross linking (Figures 3E and S4K). Comparing infected
to uninfected cells and correcting for non-specific binding of pro-
teins to the FLAG-beads, we identified several proteins that were
enriched in infected samples above the significance cut-off (p%
0.01, Figure 3E; Data S1). Some of these proteins are known
GBP1-interacting proteins such as g-actin (ACTG1), myosin light
polypeptide 6 (MYL6), and myosin regulatory light chain 12a
(MYL12A; Forster et al., 2014; Ostler et al., 2014). The most
prominent infection-specific GBP1 interaction partner we de-
tected was caspase-4, which supported results from micro-
scopy. To establish that this interaction is physiologically rele-
vant during infection, we repeated immunoprecipitation
experiments using antibodies against endogenous GBP1 from
THP-1 WT cells (this time without prior cross linking). In agree-
ment with our proteomics results, endogenous GBP1 interacted
with caspase-4 only during STm infection, pointing toward its
specific and crucial role in enabling LPS-sensing by caspase-4
(Figure 3F). In contrast, no stable interaction with caspase-1
was observed upon immunoprecipitation of endogenous GBP1
without or with infection (Figure 3F).
Taken together, these results indicated that GBP1 has two
modes of assembling caspase-containing complexes depend-
ing on the infecting pathogen: (1) by proxy through Tg vacuole
and parasite membrane disruption and release of Tg-DNA into
the cytosol to trigger activation of the AIM2 inflammasome,
and (2) by direct recruitment and interaction with caspase-4 on
the surface of STm.
Caspase-1, but Not Caspase-4, Can Cleave GBP1
The noncanonical inflammasome in mouse macrophages in-
volves sequential activation of caspase-4/11 and caspase-1,
wherein caspase-4/11 activation precedes caspase-1. As both
caspases are independently activated in IFNg-stimulated human
macrophages infected with STm (Fisch et al., 2019a), we wanted
to investigate whether a crosstalk existed between the two path-
ways. This was also pertinent given a previous report of cas-
pase-1-mediated cleavage of GBP1 in human umbilical vein
endothelial cells (HUVECs) (Naschberger et al., 2017); however,
the functional consequences of GBP1 proteolysis during infec-
tion were not investigated in that study. Noncanonical inflamma-some activation during LPS-transfection is a cell-intrinsic pro-
cess that involves K+ efflux-mediated activation of caspase-1
(Kayagaki et al., 2011; R€uhl and Broz, 2015). We therefore first
wanted to verify that caspase-1 and caspase-4 are activated
within the same STm-infected macrophage. Our results showed
a perfect correlation between bacterial targeting by GBP1-
CASP4 and pyroptosis, and we indirectly quantified caspase-1
activation by measuring ASC speck formation. Indeed, single-
cell microscopy confirmed that 80% of cells with GBP1+-
CASP4+ STm (indicating active caspase-4), also had ASC
specks (active caspase-1) (Figure 4A). Notably, caspase-4 was
not recruited to ASC specks, which is consistent with previous
work (Thurston et al., 2016)(Figures 4A and 4B). As these results
suggested dual activation of caspase-1 and caspase-4 in the
same cell, we investigated whether and how GBP1 proteolysis
might affect caspase-4 recruitment to STm.
We therefore examined the impact of caspase-1-mediated
cleavage of GBP1 at the surface-exposed Asp192 residue that
generates a stable p47 GBP1 C-terminal fragment (Figure 4C).
Of note, phylogenetic analysis of representative GBPs (Shenoy
et al., 2012) revealed that the Asp residue required for caspase-
1 cleavage-site was present in all primates and absent in most ro-
dents, including mice (Figure 4C). Infection of THP-1 with STm
indeed confirmed that GBP1 is cleaved into a 47-kDa fragment
that is prominently detected in cell culture supernatants. GBP1
proteolysis could be prevented by silencing caspase-1, but not
caspase-4, confirming the dominant role of caspase-1 in the pro-
cess (Figure 4D). LPS+Nigericin treatment for chemical activation
of caspase-1 served as a positive control and also led to p47
GBP1 production. As expected with the lack of caspase-1 activa-
tion during Tg infection (Fisch et al., 2019a), GBP1 proteolysis
could not be detected in Tg-infected THP-1 cells (Figure 4D).
To confirm proteolysis of GBP1 at the Asp192 residue, we
used a non-cleavable (D192E) variant. We created THP-1
DGBP1 cells expressing the non-cleavable GBP1D192E mutant
without or with an mCherry tag (THP-1 DGBP1+Tet-GBP1D192E
and THP-1 DGBP1+Tet-mCH-GBP1D192E cells; Figure S5A).
Immunoblotting of GBP1 from STm-infected IFNg-primed mac-
rophages revealed caspase-1 activation and formation of p47
GBP1 from cells expressing WT GBP1 but not GBP1D192E (Fig-
ure 4E). Together, these results point toward the specificity of
caspase-1 in cleaving GBP1, and that neither caspase-4 nor
caspase-8 (active during Tg infection) can replace its role.
Caspase-1-Cleaved GBP1 Fragments Cannot Traffic to
Microbial Vacuoles or Mediate Cell Death
AsGBP1 can be cleaved by caspase-1, wewanted to investigate
how this affects the pathogen-proximal activities of GBP1 in
enabling PAMP access and triggering cell death. We infected
mCH-GBP1D192E-expressing cells with STm and quantified
GBP1 recruitment to bacteria. Consistent with a lack of role for
GBP1 in SCV lysis, the proportion of GBP1+ STm was similar
in cells expressing GBP1 WT and GBP1D192E (Figure 5A). How-
ever, the mean fluorescence intensity and the thickness of the
protein coat of mCH-GBP1 around individual, decorated STm
was markedly higher in cells expressing the GBP1D192E variant
(Figure 5B), even though the expression and fluorescence of




Figure 4. Caspase-1, but Not Caspase-4, Cleaves GBP1 at Asp192 during Salmonella Infection
(A and B) Representative immunofluorescence images (A) and quantification (B) of ASC speck formation and GBP1+caspase-4 recruitment to STm from IFNg-
primed THP-1 DGBP1+Tet-mCH-GBP1+YFP-CASP4C258S infected with STm SL1344 (MOI = 30) for 2 h. Cells were treated with Dox to induce GBP1 expression
or left UT. Yellow arrowheads indicate position of some STm within cells (DNA-staining dye). Red: mCH-GBP1; cyan: ASC; green: YFP-caspase-4; blue: nuclei.
Scale bar, 10 mm.
(C) Crystal structure of human GBP1 (PDB: 1F5N) with GTPase domain highlighted in cyan, C-terminal helical domain in green and surface-exposed aspartate
D192 in red (top). Multiple sequence alignment of human, primate, and rodent GBP1 orthologs depicting the caspase-1 cleavage site (cyan) surrounding Asp192
of human GBP1.
(D) Representative immunoblots from lysates (lys.) or culture supernatants (sup.) of THP-1WT, transfected with the indicated siRNA and infected with type I Tg for
6 h, STm SL1344 for 4 h, and treated with LPS and Nigericin for 90 min.
(E) Representative immunoblots from lys. or culture sup. of THP-1 DGBP1+Tet-GBP1WT or GBP1D192E cells treated with IFNg and Dox as indicated and infected
with STm SL1344 for 4 h or left uninfected (UI).
Graph in (B) showsmean ± SEM of n = 3 independent experiments. p values in in (B) from two-way ANOVA following adjustment for multiple comparisons; ns, not
significant.
See also Figure S5.
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OPEN ACCESS(Figure S5B). In agreement with increased amounts of GBP1
covering cytosolic bacteria, more STm-infected GBP1D192E cells
underwent pyroptosis, as measured with propidium iodide (PI)
uptake and lactate dehydrogenase (LDH) release assays, than
WT cells, but released similar levels of IL-1b (Figure 5B). This
finding is consistent with amajor role for GBP1 in promoting cas-
pase-4-driven pyroptosis, but not canonical caspase-1 activa-
tion, which is responsible for IL-1b production (Kortmann et al.,
2015; Reyes Ruiz et al., 2017). These results led us to speculate
that cleavage of GBP1 reduces the cellular pool of functional full-
length GBP1, and its cleaved fragments do not support cell-
death-related roles. Indeed, DGBP1 cells reconstituted with
GBP11-192 or GBP1193-592 with or without mCherry-tag using
our Dox-inducible system (Figure S5C) revealed that neither
fragment was recruited to STm (Figure 5C) nor supported
enhanced pyroptosis (Figure 5D). As caspase-1 is not activated
during Tg infection, we anticipated that Tg targeting and
apoptosis would be similar in cells expressing GBP1 WT or
GBP1D192E. Indeed, the proportion of Tg-PVs decorated with
GBP1 WT and GBP1D192E was similar (Figure 5E) and apoptosis
remained unaffected (Figure 5F).
In summary, these results suggested that active caspase-1
cleaves a portion of the cellular GBP1 pool and generates protein8 Cell Reports 32, 108008, August 11, 2020fragments that cannot (1) target cytosolic STm, (2) recruit cas-
pase-4, or (3) enhance pyroptosis induction. Because IL-1bmatu-
rationwas not affected byGBP1D192E mutation, we speculate that
this caspase-1-driven feedback mechanism balances caspase-1
and -4-driven cell death and caspase-1-driven IL-1b maturation
during STm infection. Moreover, as caspase-1 does not
contribute to cell death during Tg-infection, this proteolytic feed-
back regulation is pathogen specific.
DISCUSSION
IFNg-inducible GBPs have emerged as important proteins in host
defense against a range of pathogens (Kutsch et al., 2020; Man
etal., 2017;Meunier andBroz, 2016;Pilla-Moffett etal., 2016;Saeij
and Frickel, 2017; Santos et al., 2020; Tretina et al., 2019; Wandel
et al., 2020; Xavier et al., 2020). In this study, we have established
that human GBP1 is essential for the breakdown of PVMs and Tg
parasites through the use of two single-cell assays, combinedwith
the artificial intelligence-driven image analysis pipeline HRMAn,
that are adaptable for other pathogens (Fisch et al., 2019b). In
contrast to Tg, GBP1 only decorates cytosolic STm and forms a







Figure 5. Caspase-1-Driven GBP1 Proteolysis Regulates Cell Death during Salmonella, but Not Toxoplasma, Infection
(A) Representative immunofluorescence images and quantification of recruitment of GBP1 to STm in IFNg-primed and Dox-treated THP-1 DGBP1+Tet-mCH-
GBP1 or mCH-GBP1D192E cells infected with STm SL1344-GFP (MOI = 30) for 2 h. Red: mCH-GBP1; Gray: STm; Blue: Nuclei. Scale bar, 10 mm.
(B) Representative immunofluorescence images as rainbow intensity diagram of GBP1 WT or D192E recruitment to STm SL1344-GFP at 2 h p.i. (left) and
quantification of fluorescence intensity and coat thickness measured as full-width half maximum (FWHM) of the radial intensity distribution surrounding the STm
centroid (yellow asterisks; right). Scale bar, 1 mm. N = number of quantified GBP1+ bacteria in the respective condition.
(C) Left: IL-1b ELISA from the indicated THP-1 cells primed with IFNg and Dox and infected with STm SL1344 (MOI = 30) at 4 h post-infection. Middle: real-time
propidium iodide (PI) uptake assay from IFNg-primed THP-1 cells of the indicated genotypes and infected with STm SL1344 for 4 h. Right: LDH release assay to
measure cell death at 4 h p.i. with STm SL1344.
(D) Representative immunofluorescence image of mCherry-tagged GBP1 fragments in IFNg- and Dox-primed THP-1 DGBP1+Tet cells expressing the indicated
GBP1 fragment infected with STm SL1344 (MOI = 30) for 2 h. Red: mCH-GBP1; white: STm; blue: nuclei. Scale bar, 10 mm.
(E) Area under the curve (AUC) from 4 h live PI uptake cell death assay in THP-1 WT or THP-1 DGBP1+Tet-GBP1 cells expressing either GBP1 fragment 1-192 or
193-592, pre-stimulated with IFNg only, with IFNg and Dox to induce GBP1 expression or left UT and infected with STm SL1344 (MOI = 30).
(F) Representative immunofluorescence images and quantification of recruitment of GBP1 in IFNg-primed and Dox-treated THP-1 DGBP1+Tet-mCH-GBP1 or
mCH-GBP1D192E cells infected with type I or type II Tg for 6 h. Red: mCH-GBP1; gray: Tg; blue: nuclei. Scale bar, 10 mm.
(G) AnnV-Glo assay of THP-1 WT and DGBP1 cells stably reconstituted with Tet-GBP1 WT or GBP1D192E as indicated, infected with type I or type II Tg for 18 h.
Plotted as AUC from real-time assays.
Graphs in (A), (C), (E), (F), and (G) showmean ±SEM from n = 3 independent experiments and in (B) representative of n = 3 independent experiments. ***p% 0.001,
****p% 0.0001 for indicated comparisons in (B) from nested Student’s t test comparingmeans of the n = 3 experiments, in (A) from one-way ANOVA and in (C), (E),
and (F) from two-way ANOVA following adjustment for multiple comparisons; ns, not significant.
See also Figure S5.
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OPEN ACCESSto limit pyroptosis. These findings provide important insights on
this key GTPase in human macrophages.
As the forerunner of the human GBP family, GBP1 has been
extensively studied structurally and biochemically. We add the
role of recruiting caspase-4 to STm dependent on functional
GTPase activity and isoprenylation, which is in line with previousfindings on mouse and human GBPs in vitro and in cellulo (Brit-
zen-Laurent et al., 2010; Kohler et al., 2019; Nantais et al., 1996;
Piro et al., 2017; Prakash et al., 2000; Shydlovskyi et al., 2017;
Stickney and Buss, 2000). Recent work also points towards a
role for GMP production in NLRP3 activation during
C. trachomatis infection (Xavier et al., 2020).Cell Reports 32, 108008, August 11, 2020 9
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with the IRG proteins has been extensively studied (Degrandi
et al., 2007; Haldar et al., 2013, 2014; Hunn et al., 2008; Kim
et al., 2012; Miyairi et al., 2007; Shenoy et al., 2007; Singh
et al., 2006, 2010; Tiwari et al., 2009; Traver et al., 2011; Virreira
Winter et al., 2011). Uniquely inmice, two chromosomal loci each
encodemembers of the Gbp (11 genes on Chr 3 and Chr 5) and
IRG (23 genes on Chr 11 and Chr 18) families. Deletion of all
mGbps on Chr3 (DGbpChr3) abrogates Tg vacuole rupture in
macrophages and these mice are highly susceptible to Tg infec-
tion (Yamamoto et al., 2012). Single deletion of mGbp1 (Selleck
et al., 2013) or mGbp2 (Degrandi et al., 2013) also results in
enhanced susceptibility to Tg in vivo and in vitro. mGbp2 can ho-
modimerize or form heterodimers with mGbp1 or mGbp5 before
recruitment and attack of Tg vacuoles (Kravets et al., 2016).
However, in themouse, the hierarchical recruitment of IRG family
GTPases to Tg vacuoles precedes the recruitment of Gbp family
members. No Gbps are recruited to Tg in Irgm1/Irgm3/murine
cells, pointing to their pivotal role in this process (Haldar et al.,
2013). In addition to the absence of IRGs in humans, a direct
role for individual GBPs in Tg vacuole disruption has not been
demonstrated for GBPs before, even though mGbp2 has been
found to localize inside Tg (Kravets et al., 2016), and vacuolar
membrane integrity is not compromised in the absence of
mGbp1, mGbp2 or all Gbps on chromosome 3 (Degrandi et al.,
2013; Selleck et al., 2013; Yamamoto et al., 2012).
Our finding that GBP1 only targets bacteria already in the
cytosol are consistent with bacterial staining with Gal-8, a
marker for damaged endomembranes (Thurston et al., 2012).
Furthermore, mouse Gbp recruitment is reduced in macro-
phages lacking Gal-3, which normally labels Legionella (Creasey
and Isberg, 2012; Feeley et al., 2017; Liu et al., 2018; Pilla et al.,
2014) or Yersinia (Feeley et al., 2017) expressing secretion sys-
tems that trigger damage of bacterial-containing vacuoles.
Work with bacterial mutants that readily access the cytosol,
such as Legionella pneumophila DsdhA and STm DsifA, also re-
vealed no differences in cytosolic bacteria in mouse DGbpChr3
macrophages (Pilla et al., 2014). Similarly, release of Francisella
novicida into the cytosol was shown to be independent of mouse
Gbps (Man et al., 2015; Meunier et al., 2015). It is plausible that in
human macrophages GBP1 is dispensable for release of STm
into the cytosol, even though Gbps encoded at mouse Chr3
and mGbp2 have previously been implicated in this process in
murine cells (Meunier et al., 2014). Indeed, STm escape to the
cytosol requires its SPI-1 T3SS (Knodler et al., 2014; Malik-
Kale et al., 2012; Radtke et al., 2007; Stévenin et al., 2019),
and it will be interesting to test whether humanGBP1 recruitment
differs when macrophages are infected with STm that are defi-
cient for SPI-1. Furthermore, it is tempting to speculate that hu-
man GBP1 recruitment to vacuolar STm is prevented by a bac-
terial virulence factor. Indeed, anti-GBP1 bacterial effectors
have been identified in Shigella flexneri (Li et al., 2017; Piro
et al., 2017; Wandel et al., 2017). Importantly, deletion of GBP1
drastically increased the survival of STm in IFNg-primed human
macrophages. However, these results should be interpretedwith
caution, as early gasdermin D (GSDMD)-pore formation prior to
full-blown pyroptosis may enable the entry of gentamicin into
cells and affect the viability of bacteria in such assays. Further10 Cell Reports 32, 108008, August 11, 2020work should also investigate whether other human GBPs also
assemble alongside or assist GBP1 during STm infection.
Our work also shows unique GBP1 action during infection by
these diverse pathogens whose distinct PAMPs are recognized
by downstream innate immune pathways. Click-chemistry re-
vealed that Tg-DNA is present in the cytoplasm of GBP1-ex-
pressing macrophages that subsequently induces the assembly
of the atypical AIM2-ASC-caspase-8 SMOC and apoptosis. Su-
per-resolution imaging structure of a caspase-8 containing AIM2
inflammasome closely resembles previously published struc-
tures of caspase-8 in NLRP3/NLRC4 inflammasomes (Man
et al., 2013, 2014), revealing donut-like ASC rings enclosing
AIM2 and caspase-8. Super-resolution microscopy during
STm infection showed that GBP1 and caspase-4 formed a dense
coat on STm, which reduced bacterial staining with anti-LPS
antibody. Whether this reduced antibody access was due to
the dense GBP1/caspase-4 coat or blocking of the LPS epitope
by caspase-4 cannot be definitively distinguished; however,
GBP1 alone (staining in DCASP4 cells) could not block access
to the epitope. As caspase-4 by itself could not recruit to bacteria
(Fisch et al., 2019a), we speculate that GBP1 is involved in
exposing parts of the LPS that are buried deeper within themem-
brane. A direct interaction of GBP1 with LPS has been reported
recently (Kutsch et al., 2020; Santos et al., 2020) and additionally
suggested for mGbp5 (Santos et al., 2018). Our findings there-
fore support the hypothesis that isoprenylated, GTPase-activity
competent GBP1 has a ‘‘detergent-like’’ function to open the
bacterial outer membrane for caspase-4 to gain access to the
otherwise-hidden lipid A of STm-LPS, which is consistent with
recent reports (Kutsch et al., 2020).
We also uncovered a physiological role for GBP1-proteolysis
by caspase-1 that was previous reported in vitro using HUVECs
and in vivo from cerebrospinal fluid of meningitis patients
(Naschberger et al., 2017), which we confirmed during natural
infection of macrophages with STm. Notably, despite the 40%
to 98% sequence similarity between human and mouse GBPs
(Kim et al., 2011; Shenoy et al., 2007), and the conservation of
Asp192 in other primate GBP1 sequences, Asp192 is absent in
the closest murine homolog, mGbp2 (Olszewski et al., 2006),
which is therefore unlikely to be regulated in this manner. Intrigu-
ingly, this finding mirrors our recent identification of the proteol-
ysis of human, but not mouse, SQSTM1/p62 by caspase-8 at a
conserved residue found in other mammalian SQSTM1/p62 se-
quences (Sanchez-Garrido et al., 2018). During STm infection,
caspase-1 plays a dominant role in IL-1b maturation whereas
IFNg-induced GBP1 exclusively enhances caspase-4-driven
pyroptosis. As a result, caspase-1-dependent proteolysis of
GBP1 impaired GBP1-caspase-4-driven pyroptosis, but not
caspase-1-driven IL-1bmaturation. Thus, besides directly aiding
the release or access to PAMPs for detection by caspases,
GBP1 itself is a target of caspase-1 and a key regulatory hub
that modulates host cell death. This contrasts our discovery
of the ubiquitin-conjugating enzyme UBE2L3 as an indirect
target of caspase-1 that specifically controls IL-1b production,
but not pyroptosis (Eldridge et al., 2017). At the whole
organism level, these mechanisms potentially enable differential
responses based on the strength of the activating stimulus.
Enhanced IL-1b production for adaptive immunity may be
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OPEN ACCESSbalanced by cell death that could enable pathogen uptake by
other cell types such as neutrophils. Studies on cellular targets
of caspases may therefore provide insights on homeostasis
and disease.
Common themes also emerge from work on human and
mouse GBPs. For instance, human GBP1 and mouse Gbp2
accumulate on vesicles generated through sterile damage,
which suggests they could detect endogenous luminal ligands
in the cytosol, such as in endogenous sulfated lipids (Bradfield,
2016; Feeley et al., 2017; Piro et al., 2017). The presence of
Gal-3/Gal-8 and GBPs at sites of damaged membranes sug-
gests GBPs may be assisted in sensing damage by other pro-
teins, including other IFN-induced genes. Undoubtedly, future
work in the area will focus on finding how human GBPs are tar-
geted to diverse microbes, the ligands they sense and how
they are regulated.
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Stévenin, V., Chang, Y.Y., Le Toquin, Y., Duchateau, M., Gianetto, Q.G., Luk,
C.H., Salles, A., Sohst, V., Matondo, M., Reiling, N., and Enninga, J. (2019). Dy-
namic growth and shrinkage of the salmonella-containing vacuole determines
the intracellular pathogen niche. Cell Rep. 29, 3958–3973.e7.
Stickney, J.T., andBuss, J.E. (2000). Murine guanylate-binding protein: incom-
plete geranylgeranyl isoprenoid modification of an interferon-g-inducible gua-
nosine triphosphate-binding protein. Mol. Biol. Cell 11, 2191–2200.
Thurston, T.L.M.M., Wandel, M.P., von Muhlinen, N., Foeglein, A., and
Randow, F. (2012). Galectin 8 targets damaged vesicles for autophagy to
defend cells against bacterial invasion. Nature 482, 414–418.
Thurston, T.L.M.M., Matthews, S.A., Jennings, E., Alix, E., Shao, F., Shenoy,
A.R., Birrell, M.A., and Holden, D.W. (2016). Growth inhibition of cytosolic sal-
monella by caspase-1 and caspase-11 precedes host cell death. Nat. Com-
mun. 7, 13292.14 Cell Reports 32, 108008, August 11, 2020Tiwari, S., Choi, H.P., Matsuzawa, T., Pypaert, M., and MacMicking, J.D.
(2009). Targeting of the GTPase Irgm1 to the phagosomal membrane via
PtdIns(3,4)P(2) and PtdIns(3,4,5)P(3) promotes immunity to mycobacteria.
Nat. Immunol. 10, 907–917.
Traver, M.K., Henry, S.C., Cantillana, V., Oliver, T., Hunn, J.P., Howard, J.C.,
Beer, S., Pfeffer, K., Coers, J., and Taylor, G.A. (2011). Immunity-related
GTPase M (IRGM) proteins influence the localization of guanylate-binding pro-
tein 2 (GBP2) by modulating macroautophagy. J. Biol. Chem. 286, 30471–
30480.
Tretina, K., Park, E.S., Maminska, A., and MacMicking, J.D. (2019). Interferon-
induced guanylate-binding proteins: guardians of host defense in health and
disease. J. Exp. Med. 216, 482–500.
Tripal, P., Bauer, M., Naschberger, E., Mörtinger, T., Hohenadl, C., Cornali, E.,
Thurau, M., and St€urzl, M. (2007). Unique features of different members of the
human guanylate-binding protein family. J. Interf. Cytokine Res. 27, 44–52.
Virreira Winter, S., Niedelman, W., Jensen, K.D., Rosowski, E.E., Julien, L.,
Spooner, E., Caradonna, K., Burleigh, B.A., Saeij, J.P.J.J., Ploegh, H.L., and
Frickel, E.M. (2011). Determinants of GBP recruitment to Toxoplasma gondii
vacuoles and the parasitic factors that control it. PLoS ONE 6, e24434.
Wallet, P., Benaoudia, S., Mosnier, A., Lagrange, B., Martin, A., Lindgren, H.,
Golovliov, I., Michal, F., Basso, P., Djebali, S., et al. (2017). IFN-g extends the
immune functions of Guanylate Binding Proteins to inflammasome-indepen-
dent antibacterial activities during Francisella novicida infection. PLoS Pathog.
13, e1006630.
Wandel, M.P., Pathe, C., Werner, E.I., Ellison, C.J., Boyle, K.B., von der Mals-
burg, A., Rohde, J., and Randow, F. (2017). GBPs inhibit motility of Shigella
flexneri but are targeted for degradation by the bacterial ubiquitin ligase
IpaH9.8. Cell Host Microbe 22, 507–518.e5.
Wandel, M.P., Kim, B.H., Park, E.S., Boyle, K.B., Nayak, K., Lagrange, B.,
Herod, A., Henry, T., Zilbauer, M., Rohde, J., et al. (2020). Guanylate-binding
proteins convert cytosolic bacteria into caspase-4 signaling platforms. Nat.
Immunol., 10.1038.
Xavier, A., Al-Zeer, M.A., Meyer, T.F., and Daumke, O. (2020). hGBP1 xoordi-
nates Chlamydia restriction and inflammasome activation through sequential
GTP hydrolysis. Cell Rep. 31, 107667.
Yamamoto, M., Okuyama, M., Ma, J.S., Kimura, T., Kamiyama, N., Saiga, H.,
Ohshima, J., Sasai, M., Kayama, H., Okamoto, T., et al. (2012). A cluster of
interferon-g-inducible p65GTPases plays a critical role in host defense against
Toxoplasma gondii. Immunity 37, 302–313.
Young, J., Dominicus, C., Wagener, J., Butterworth, S., Ye, X., Kelly, G., Or-
dan, M., Saunders, B., Instrell, R., Howell, M., et al. (2019). A CRISPR platform
for targeted in vivo screens identifies Toxoplasma gondii virulence factors in
mice. Nat. Commun. 10, 3963.
Zwack, E.E., Feeley, E.M., Burton, A.R., Hu, B., Yamamoto, M., Kanneganti,
T.-D., Bliska, J.B., Coers, J., and Brodsky, I.E. (2017). Guanylate binding pro-
teins regulate inflammasome activation in response to hyperinjected Yersinia
translocon components. Infect. Immun. 85, e00778-e16.
Article
ll
OPEN ACCESSSTAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit monoclonal anti-AIM2 Cell Signaling Technologies Cat#12948; RRID:AB_2798067
Rabbit polyclonal anti-ASC Adipogen Cat#AG-25B-006
Mouse monoclonal anti-c-myc (Clone
9E10)
Merck Cat#MABE282; RRID:AB_11213164
Mouse monoclonal anti-Caspase-1 (Clone
Bally-1)
Adipogen Cat#AG-20B-0048; RRID:AB_2490257
Mouse monoclonal anti-Caspase-8 Cell Signaling Technologies Cat#9746; RRID:AB_2275120
Mouse monoclonal anti-Flag M2 Sigma Cat#F3165; RRID:AB_259529
Goat polyclonal anti-Galectin-8 R&D Systems Cat#AF1305; RRID:AB_2137229
Mouse monoclonal anti-GBP1 Home-made (Frickel lab) N/A
Rabbit polyclonal anti-mCherry Abcam Cat#ab167453; RRID:AB_2571870
Rabbit polyclonal anti-panGBP Home-made (Frickel lab) N/A
Rabbit polyclonal anti-Salmonella Abcam Cat#ab35156; RRID:AB_777811
Mouse monoclonal anti-Salmonella
Typhimurium LPS (clone 1E6)
Abcam Cat#ab8274; RRID:AB_306423
Rabbit polyclonal anti-GFP/YFP Abcam Cat#ab6556; RRID:AB_305564
Mouse monoclonal anti-b-Actin Sigma Cat#A5316; RRID:AB_476743
Bacterial and Virus Strains
Salmonella Typhimurium SL1344 WT Hoiseth and Stocker (1981), a kind gift from
Jorge Galan (Yale University)
N/A
Salmonella Typhimurium SL1344-GFP Fisch et al., 2019a N/A
Chemicals, Peptides, and Recombinant Proteins




3xFlag peptide Sigma Cat#F4799
CellMask Deep Red Invitrogen Cat#H32721
Flag(M2)-agarose beads Sigma Cat#A2220; RRID:AB_10063035
Critical Commercial Assays
RealTime-Glo Annexin V Apoptosis Assay Promega Cat#JA1001
IL-1 beta Human Uncoated ELISA Kit Invitrogen Cat#88-7261; RRID:AB_2575052
Pierce BCA protein assay kit Thermo Scientific Cat#23225
Silver Stain Plus Kit Biorad Cat#1610449
High-capacity cDNA synthesis kit Applied Biosystems Cat#4368813
PowerUP SYBR green Applied Biosystems Cat#A25742
Click-iT EdU Cell Proliferation Kit for
Imaging, Alexa Fluor 647 dye
Invitrogen Cat#C10340
Alexa Fluor 647 Protein Labeling Kit Invitrogen Cat#A20173
Deposited Data
Raw and analyzed data This paper https://dx.doi.org/10.17632/gkgrk7d8hg.1
Experimental Models: Cell Lines
HEK293T The Francis Crick Institute, Cell Services RRID:CVCL_0063
HFF The Francis Crick Institute, Cell Services RRID:CVCL_XB54
THP-1 DCASP4 Schmid-Burgk et al., 2015 N/A
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
THP-1 DGBP1 Fisch et al., 2019a N/A
THP-1 DGBP1+Tet-EV Fisch et al., 2019a N/A
THP-1 DGBP1+Tet-GBP1 Fisch et al., 2019a N/A
THP-1 DGBP1+Tet-GBP1+GFP11 This study N/A
THP-1 DGBP1+Tet-GBP11-192 This study N/A
THP-1 DGBP1+Tet-GBP1193-592 This study N/A
THP-1 DGBP1+Tet-GBP1D192E This study N/A
THP-1 DGBP1+Tet-mCH-GBP1 Fisch et al., 2019a N/A
THP-1 DGBP1+Tet-mCH-GBP1 + YFP-
CASP4C258S




THP-1 DGBP1+Tet-mCH-GBP11-192 This study N/A








THP-1 WT ATCC Cat#TIB-202; RRID:CVCL_0006
THP-1 WT+GFP11 This study N/A
THP-1 WT+Tet-CASP8-Flag This study N/A
THP-1 WT+Tet-CASP8-Flag + myc-AIM2 This study N/A
Experimental Models: Organisms/Strains
Type I (RH) Toxoplasma gondii-GFP-Luc Kim et al., 2007 N/A
Type II (Prugniaud) Toxoplasma gondii-
GFP-Luc
Kim et al., 2007 N/A
Type II (Prugniaud) Toxoplasma gondiiDHpt Moritz Treeck, The Francis Crick Institute,
London, UK
N/A




Oligonucleotide primers for molecular
cloning
This study Table S1
Oligonucleotide primers for qPCR This study Table S1
siRNA for human CASP1 Dharmacon Cat#L-004401
siRNA for human CASP4 Dharmacon Cat#L-004404
siRNA for human CASP5 Dharmacon Cat#L-004405
siRNA for human GSDMD Dharmacon Cat#L-016207
Negative control siRNA Dharmacon Cat#D-001810
Recombinant DNA
Plasmid pcDNA3-CASP8 Stennicke and Salvesen, 1997 Addgene #11817; RRID:Addgene_11817
Plasmid LentiCRISPRv2 Sanjana et al., 2014 Addgene #52961; RRID:Addgene_52961
Plasmid pLenti-Tet-CASP8-3xFlag This study N/A
Plasmid pLenti-Tet- 3xFlag-GBP1 This study N/A
Plasmid pGene-GBP1 Home-made (Frickel lab) N/A
Plasmid pLenti-Tet Fisch et al., 2019a N/A
Plasmid pLenti-Tet-mCH-GBP1 Fisch et al., 2019a N/A
Plasmid pLenti-Tet-GBP1 Fisch et al., 2019a N/A
Plasmid pMX-CMV-YFP-CASP4C258S Fisch et al., 2019a N/A
(Continued on next page)





REAGENT or RESOURCE SOURCE IDENTIFIER
Plasmid pcDNA3-myc-AIM2 Khare et al., 2014 Addgene #73958; RRID:Addgene_73958
Plasmid pLEX-MCS-ASC-GFP de Almeida et al., 2015 Addgene #73957; RRID:Addgene_73957
Plasmid pLEX-MCS-myc-AIM2 This study N/A
Plasmid pLenti-P2A-Puro This study N/A
Plasmid pEGFP-C1 Clontech N/A
Plasmid pGRA-HA-HPT Coppens et al., 2006 N/A
Software and Algorithms
FlowJo version 10.3 FlowJo, LLC https://www.flowjo.com/
Fiji Schindelin et al., 2012 https://fiji.sc/
MaxQuant version 1.6.0.13 MPI of Biochemistry, Martinsried, Germany https://www.maxquant.org/
LAS-AF software Leica Microsystems N/A
DeltaVision GE Healthcare Life Sciences (Cytiva) N/A
Imaris version 8.3.1. Oxford Instruments https://imaris.oxinst.com/
TrakEM2 Cardona et al., 2012 https://imagej.net/TrakEM2
KNIME Analytics Platform version 4.1.2 Berthold et al., 2008 https://www.knime.com/
HRMAn Fisch et al., 2019b https://hrman.org/
Prism version 8.1.1 GraphPad Inc. https://www.graphpad.com/





Further information and requests for resources and reagents should be directed to andwill be fulfilled by the LeadContact, Eva-Maria
Frickel (E.frickel@bham.ac.uk).
Materials Availability
All plasmids and cell lines generated and used in this study are available from the lead contact on request.
Data and Code Availability
TheMass spectrometry dataset is included in this study (Data S1). Quantification datasets are available fromMendeley data (https://
doi.org/10.17632/gkgrk7d8hg.1). Any other data supporting the current study are available from the lead contact.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
THP-1 (TIB-202, ATCC, Male cell line, RRID:CVCL_0006) were maintained in RPMI with GlutaMAX (GIBCO) supplemented with 10%
heat-inactivated FBS (Sigma), at 37C in 5% CO2 atmosphere. THP-1 cells were differentiated with 50 ng/mL phorbol 12-myristate
13-acetate (PMA, P1585, Sigma) for 3 days followed by a rested for 2 days in complete medium without PMA. Cells were not used
beyond passage 20. HEK293T (Female cell line, RRID:CVCL_0063) and human foreskin fibroblasts (HFF, Male cell line,
RRID:CVCL_XB54) weremaintained in DMEMwith GlutaMAX (GIBCO) supplemented with 10%FBS at 37C in 5%CO2 atmosphere.
Tg expressing luciferase/eGFP (RH type I and Prugniaud (Pru) type II) were maintained by serial passage onmonolayers of HFF cells.
All cell culture was performed without addition of antibiotics unless otherwise indicated. Cell lines were routinely tested for myco-
plasma contamination by PCR and agar test. Please refer to the Key Resources Table for an overview of all cell lines made/ used
in this.
STm SL1344-GFP (with pFPV25.1 plasmid) wasmaintained under Ampicillin selection (11593027, GIBCO). STm SL1344WT strain
was maintained in the presence of Streptomycin (11860038, GIBCO) selection.
METHOD DETAILS
Cell treatments
Cells were stimulated for 16 h prior to infection in complete medium at 37Cwith addition of 50 IU/mL human IFNg (285-IF, R&D Sys-
tems). Induction of Doxycycline-inducible cells was performed with 200 ng/mL Doxycycline overnight (D9891, Sigma). To chemically
activate caspase-1, cells were treated with 10 mM Nigericin (N1495, Invitrogen) and 100 mg/mL LPS-Sm (IAX-100-011, Adipogen).Cell Reports 32, 108008, August 11, 2020 e3
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Inducible GBP1 and caspase-8 cell lines
THP-1 DGBP1+Tet-GBP1 and THP-1 DGBP1+Tet-mCH-GBP1 have been published before and the THP-1 WT+Tet-CASP8-Flag
cells were created identically using Lentiviral transductions (Fisch et al., 2019a).
To create the caspase-8-3xFlag expressing Dox-inducible plasmid (pLenti-Tet-CASP8-3xFlag), the empty vector backbone was
digested with BamHI, CASP8 ORF was amplified from pcDNA3-CASP8 by PCR (Addgene #11817, a gift from Guy Salvesen) (Sten-
nicke and Salvesen, 1997), 3xFlag was amplified from LentiCRISPRv2 (Addgene #52961, a gift from Feng Zhang) (Sanjana et al.,
2014) and all fragments assembled with a Gibson assembly. Similarly, to create the 3xFlag-GBP1 expressing Dox-inducible plasmid
(pLenti-Tet- 3xFlag-GBP1), the empty vector backbone was digested with BamHI, GBP1 ORF was amplified from pGene-GBP1 by
PCR (Frickel lab), 3xFlag was amplified from LentiCRISPRv2 (Addgene #52961, a gift from Feng Zhang) (Sanjana et al., 2014) and all
fragments assembled with a Gibson assembly. In the same way, GBP1 fragments 1-192 and 193-592 were amplified from pGene-
GBP1 (Frickel lab) and Gibson assembled into BamHI digested pLenti-Tet (Fisch et al., 2019a) with andwithout addition of a mCherry
tag. The obtained plasmids were then transduced into THP-1 DGBP1+Tet cells (Fisch et al., 2019a) using lentiviral particles.
To make the cells expressing GBP1D192E, the pLenti-Tet-mCH-GBP1 and pLenti-Tet-GBP1 plasmids (Fisch et al., 2019a) were
mutated using site-directed mutagenesis and transduced into the THP-1 DGBP1+Tet target cells using lentiviral transduction as
described before (Fisch et al., 2019a). To make cells expressing YFP-CASP4C258S and mutated GBP1 versions, THP-1
DGBP1+Tet-mCH-GBP1K51A, +Tet-mCH-GBP1C589A or +Tet-mCH-GBP1D589-592 (Fisch et al., 2019a) were transduced with pMX-
CMV-YFP-CASP4C258S (Fisch et al., 2019a) using lentiviral particles. Please refer to the Key Resources Table and Table S1 for an
overview of all oligonucleotide primers and plasmids used for cloning PCRs.
myc-AIM2 expressing cell line
Tocreate a lentiviral vector for constitutive expressionofmyc-AIM2, theORFwas amplified frompcDNA3-myc-AIM2 (Addgene#73958,
a gift from Christian Stehlik) (Khare et al., 2014) and Gibson assembled into BstBI and BsrGI digested pLEX-MCS-ASC-GFP (Addgene
#73957, agift fromChristianStehlik) (deAlmeidaet al., 2015) tocreatepLEX-MCS-myc-AIM2. The vectorwas then transduced intoTHP-
1+Tet-CASP8-Flag cells to create THP-1+Tet-CASP8 + myc-AIM2 cells using lentiviral transduction as described above.
GFP11 expressing cell lines
To create an lentiviral vector for constitutive expression of GFP11, the sgRNA cassette from LentiCRISPRv2 (Addgene #52961, a gift
from Feng Zhang) (Sanjana et al., 2014) was removed by digestion with KpnI and EcoRI and the plasmid re-ligated using annealed
repair oligo pair 1 (see Key Resources Table and Table S1) and Quick Ligation Kit (M2200L, NEB). Next, the Cas9-ORF was removed
by digestion with XbaI and BamHI and again the vector re-ligated using annealed repair oligo pair 2 (see Key Resources Table and
Table S1), also adding a multiple cloning site, which created the vector pLenti-P2A-Puro. Next, the GFP11 ORF was amplified from
pEGFP-C1 (Clontech) and ligated into BamHI and XbaI digested pLenti-P2A-Puro, to have the GFP11-ORF in frame with the P2A-
Puro cassette, for Puromycin-selectable, constitutive expression of GFP11. The newly made vector was then transduced into
THP-1 WT and THP-1 DGBP1+Tet-GBP1 cells using Lentiviral transduction as described above.
Creation of transgenic Toxoplasma gondii
To create Tg lines that constitutively express non-fluorescent GFP1-10 fragment, the GFP1-10 ORF was amplified from pEGFP-C1
(Clontech) and Gibson-assembled into NsiI and PacI digested pGRA-HA-HPT (a gift from Moritz Treeck) (Coppens et al., 2006),
to have expression of the ORF under control of the TgGRA1 promoter.
Next the plasmid was transfected into type II (Pru) Tg DHpt (a gift fromMoritz Treeck) using nucleofection as established by Young
et al. (2019): The plasmid was linearized using PsiI-V2 and purified using phenol-chloroform precipitation and re-suspended in P3
solution (Lonza). Successful linearization was confirmed using agarose-gel electrophoresis. Next, type II (Pru) Tg DHpt were har-
vested from HFFs by syringe lysis and washed with PBS twice and then 5 3 106 parasites resuspended in P3 solution. Prior to nu-
cleofection, 25 mg linearized DNA were added to the parasites and then nucleofected using 4D-NucleofectorTM (Lonza) with setting
EO-115. Transfected parasites were then incubated for 12minutes at room temperature, followed by platting onto fresh HFF cells into
a T25 tissue culture flask. The next day, medium was replaced with complete DMEM containing 50 mg/mL xanthine and mycophe-
nolic acid (MPA) each for selection. The selection mediumwas replaced every two days and the parasites passaged normally for two
weeks when all Tg in the untransfected control had died. Successful integration of the plasmid and expression of GFP1-10 was
confirmed by immunofluorescence and immunoblotting.
Toxoplasma gondii infection
Parasite were passaged the day before infection. Tg tachyzoites were harvested from HFFs by scraping and syringe lysing the cells
through a 25 G needle. The Tg suspension was cleared by centrifugation at 50 x g for 5 min and then the parasites were pelleted by
centrifugation at 550 x g for 7 min from the supernatant, washed with complete medium, and finally re-suspended in fresh medium.
Viable parasites were counted with trypan blue and used for infection at a multiplicity of infection (MOI) of 3 for most experiments or 1
for immunofluorescence imaging. Infection was synchronized by centrifugation at 500 x g for 5 min. Two hours after infection, extra-
cellular parasites were removed with three PBS washes.e4 Cell Reports 32, 108008, August 11, 2020
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For flow cytometry analysis of GFP-fluorescence, Tg DHpt+GFP1-10 were harvested from host cells by syringe lysis, washed twice
with warm PBS and then re-suspended in PBS + 1% BSA. Parasites were analyzed on a LSR Fortessa (BD Biosciences) and data
were processed using FlowJo version 10.3 (FlowJo, LLC). For viability determination of GFP-fluorescing versus non-fluorescing Tg
the parasites were harvested and prepared identically, sorted on a FACSAria III (BD Biosciences) based on their GFP-fluorescence
and then plated onto HFFs grown confluent in wells of a 24-well plate. 5 days post infection of the HFFs, cells were fixedwith ice-cold
methanol and stained with crystal violet. Following 5 washes with PBS, plaques were imaged on a GelCount Colony Counter (Oxford
Optronix) and cell covered area determined using FIJI ImageJ.
Salmonella Typhimurium infection
One day before infection bacteria from a single colony were inoculated into 9 mL LB and grown overnight at 37C. The overnight
culture was diluted 1:50 into LB + 300 mMNaCl (746398, Sigma) and grown shaking in a closed container until an OD600 of 0.9. Bac-
teria were harvested by centrifugation at 1000 x g for 5 min, washed with serum-free cell culture medium twice and re-suspended in
1mLmedium. Cells were infected with STm at anMOI of 30 and infections were synchronized by centrifugation at 750 x g for 10 min.
Infected cells were washed 30 min post-infection three times with warm PBS (806552, Sigma) to remove extracellular bacteria and
fresh, serum-free medium containing 100 mg/mL Gentamicin (15750060, GIBCO) was added for 1 h. Medium was then replaced with
medium containing 10 mg/mL Gentamicin and the infection continued for indicated times. Bacterial MOI used for infections were
confirmed by plating on LB agar plates. For Gentamicin infection-protection assays, cells were lysed with 1 mL of PBS + 0.1% Triton
X-100 (T8787, Sigma) for 5 mins including a brief vortex to ensure complete host cell-disruption at 2 h and 18 h p.i., suspensions
diluted 1:1,000 to 1:10,000 in PBS, plated on LB-agar plates and incubated at 37C overnight. Colony forming units (CFUs) were
counted the next morning and replication calculated as fold-change normalized to the CFU at 2 h.
Real-time cell death assays and IL-1b ELISA
To measure live kinetics of cell death, 60,000 cells were seeded per well of a black-wall, clear-bottom 96-well plate (Corning) for dif-
ferentiation with PMA, treated and infected as described above. Medium was replaced with phenol-red-free RPMI supplemented
with 5 mg/mL propidium iodide (P3566, Invitrogen). The plate was sealed with a clear, adhesive optical plate seal (Applied Bio-
systems) and placed in a plate reader (Fluostar Omega, BMG Labtech) pre-heated to 37C. PI fluorescence was recorded with
top optics every 15 min for times as indicated.
Apoptosis kinetics were analyzed using the RealTime-Glo Annexin V Apoptosis Assay (JA1001, Promega) according to the man-
ufacturer’s instruction. Simultaneously with infection, detection reagent was added. Luminescence was measured using a Fluostar
Omega plate reader (BMG Labtech). No-cell, medium-only controls were used for background correction.
For IL-1b ELISA, the cell culture supernatant was harvested, cleared by centrifugation at 2000 x g for 5 minutes and diluted in the
buffer provided with the ELISA kit. ELISA was performed according to the manufacturer’s instruction. IL-1b ELISA kit was from In-
vitrogen (#88-7261, detection range 2 - 150 pg/mL).
Immunoblotting and gel staining
For immunoblotting, 0.53 106 cells were seeded per well of a 48-well plate, differentiated with PMA, pre-treated and infected. Cells
were washed with ice-cold PBS and lysed for 5 min on ice in 50 mL RIPA buffer supplemented with protease inhibitors (Protease In-
hibitor Cocktail set III, EDTA free, Merck) and phosphatase inhibitors (PhosSTOP, Roche). Lysates were cleared by centrifugation at
full speed for 15 min at 4C. BCA assay (Pierce BCA protein assay kit, 23225, Thermo Scientific) was performed to determine protein
concentration. 10 mg of total protein per sample were run on Bis-Tris gels (Novex, Invitrogen) in MOPS running buffer and transferred
on Nitrocellulose membranes using iBlot transfer system (Invitrogen). Membranes were blocked with either 5% BSA (A2058, Sigma)
or 5% dry-milk (M7409, Sigma) in TBS-T for at least 1 h at room temperature. Incubation with primary antibodies was performed at
4C overnight (Please refer to the Key Resources Table for an overview of all antibodies used in this study). Blots were developed by
washing the membranes with TBS-T, probed with 1:5000 diluted secondary antibodies in 5% BSA in TBS-T and washed again.
Finally, the membranes were incubated for 2 minutes with ECL (Immobilon Western, WBKLS0500, Millipore) and luminescence
was recorded on a ChemiDoc MP imaging system (Biorad). For silver staining of protein gels, following SDS-PAGE, the gels were
washed in ddH2O and then silver stained following the manufacturers instruction (Silver Stain Plus Kit, 1610449, Biorad).
For immunoblots of culture supernatants, cells were treated in OptiMEM (1105802, GIBCO) without serum. Proteins in the super-
natants were precipitated with 4x volume cold acetone (V800023, Sigma) overnight at20C, and pelleted by centrifugation. Pellets
were air-dried and re-suspended in 40 mL 2x Laemmli loading dye.
Identification of GBP1-interacting proteins
Sample preparation
103 106 THP-1DGBP1+Tet-Flag-GBP1 cells were seeded in 6-well plates and differentiated, pre-treated with IFNg andDoxycycline
and infected with STm as described before. 2 hours p.i. the interacting proteins were crosslinked with 1% formaldehyde (28906,
Thermo Scientific) for 10 minutes at room temperature and the reaction quenched by addition of 125 mM glycine (Sigma). Cell
were washed in ice-cold PBS and scraped from the plates. Cells were then pelleted by centrifugation and washed in PBS.Cell Reports 32, 108008, August 11, 2020 e5
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thiothreitol [DTT], 10 mM sodium fluoride, protease inhibitors (Protease Inhibitor Cocktail set III, EDTA free, Merck), phosphatase in-
hibitor cocktails (PhosSTOP, Roche)) and incubation for 15minutes on ice. Lysates were cleared by centrifugation and then added to
Flag(M2)-agarose beads (A2220, Sigma) washed three times with lysis buffer. Flag-GBP1 was captured by incubation on a rotator
overnight at 4C. Beads were thenwashed oncewith lysis buffer, three timeswith lysis buffer containing 260mMNaCl and then again
twice with lysis buffer. Proteins were eluted using 200 mg/mL 3xFlag peptide (F4799, Sigma) in lysis buffer by incubation on an orbital
shaker (1400 rpm) for 2 hours at room temperature. Samples were then prepared by adding loading dye containing 5% b-Mercap-
toethanol (Sigma) to reverse crosslinking and run on a 12% Bis-Tris polyacrylamide gel until the running front had entered the gel
roughly 5 mm.
Trypsin digestion
Samples on the SDS-PAGEwere excised as three vertical lanes each. The excised gel pieces were de-stained with 50% acetonitrile/
50 mM ammonium bicarbonate, reduced with 10 mM DTT, and alkylated with 55 mM iodoacetamide. After alkylation, the proteins
were digested with 250 ng of trypsin overnight at 37C. The resulting peptides were extracted in 2% formic acid, 1% acetonitrile and
speed vacuum dried. Prior to analysis the peptides were reconstituted in 50 ml of 0.1% TFA.
Mass spectrometry
The peptides were loaded on a 50 cmEASY-Spray column (75 mm inner diameter, 2 mmparticle size, Thermo Fisher Scientific), equip-
ped with an integrated electrospray emitter. Reverse phase chromatography was performed using the RSLC nano U3000 (Thermo
Fisher Scientific) with a binary buffer system at a flow rate of 275 nl/min. Solvent A was 0.1% formic acid, 5% DMSO, and solvent B
was 80%acetonitrile, 0.1% formic acid, 5%DMSO. The in-gel digested sampleswere run on a linear gradient of solvent B (2 - 30%) in
95.5min, total run time of 120min including column conditioning. The nano LCwas coupled to an Orbitrap Fusion Lumosmass spec-
trometer using an EASY-Spray nano source (Thermo Fisher Scientific). The Orbitrap Fusion Lumos was operated in data-dependent
acquisition mode acquiring MS1 scan (R = 120,000) in the Orbitrap, followed by HCD MS2 scans in the Ion Trap. The number of
selected precursor ions for fragmentation was determined by the ‘‘Top Speed’’ acquisition algorithm with a cycle time set at 3 s.
The dynamic exclusion was set at 30 s. For ion accumulation the MS1 target was set to 4 3 105 ions and the MS2 target to
23 103 ions. Themaximum ion injection time utilized for MS1 scans was 50ms and for MS2 scans was 300ms. The HCD normalized
collision energy was set at 28 and the ability to inject ions for all available parallelizable time was set to ‘‘true.’’
Data processing and analysis
Orbitrap .RAW files were analyzed by MaxQuant (version 1.6.0.13), using Andromeda for peptide search. For identification, peptide
length was set to 7 amino acids, match between runs was enabled and settings were kept as default. Parent ion and tandem mass
spectra were searched against UniprotKB Homo sapiens and Salmonella typhimurium databases. For the search the enzyme spec-
ificity was set to trypsin with maximum of twomissed cleavages. The precursor mass tolerance was set to 20 ppm for the first search
(used formass re-calibration) and to 6 ppm for themain search. Productmass tolerancewas set to 20 ppm. Carbamidomethylation of
cysteines was specified as fixed modification, oxidized methionines and N-terminal protein acetylation were searched as variable
modifications. The datasets were filtered on posterior error probability to achieve 1% false discovery rate on protein level. Quanti-
fication was performed with the LFQ algorithm in MaxQuant using three replicate measurements per experiment.
Quantitative RT-PCR
RNA was extracted from 0.253 106 cells using Trizol reagent (15596026, Invitrogen). RNA (1 mg) was reverse transcribed using high-
capacity cDNA synthesis kit (4368813, Applied Biosystems). qPCR used PowerUP SYBR green (A25742, Applied Biosystems) kit,
20 ng cDNA in a 20 mL reaction and primers (Please refer to the Key Resources Table and Table S1 for an overview of all oligonucle-
otide primers used for qPCR) at 1 mM final concentration on a QuantStudio 12K Flex Real-Time PCR System (Applied Biosystems).
Recorded Ct values were normalized to Ct of human HPRT1 and data plotted as DCt (Relative expression).
siRNA transfection
Cells were transfected with siRNAs two days prior to infection, at the same time the THP-1 differentiation medium was replaced with
medium without PMA. All siRNAs were used at a final concentration of 30 nM. For transfection, a 10x mix was prepared in OptiMEM
containing siRNA(s) and TransIT-X2 transfection reagent (MIR 600x, Mirus) in a 1:2 stoichiometry. Please refer to the Key Resources
Table for an overview of siRNAs used in this study.
Fixed immunofluorescence microscopy
For confocal imaging 0.253 106 THP-1 cells were seeded on gelatin-coated (G1890, Sigma) coverslips in 24-well plates. Following
differentiation, treatments and infection, cells were washed three times with warm PBS prior to fixation to remove any uninvaded
pathogens and then fixed with 4%methanol-free formaldehyde (28906, Thermo Scientific) for 15min at room temperature. Following
fixation, cells were washed again with PBS and kept at 4C overnight to quench any unreacted formaldehyde. Fixed specimens were
permeabilized with PermQuench buffer (0.2% (w/v) BSA and 0.02% (w/v) saponin in PBS) for 30 minutes at room temperature and
then stained with primary antibodies for one hour at room temperature. After three washes with PBS, cells were incubated with the
appropriated secondary antibody and 1 mg/mL Hoechst 33342 (H3570, Invitrogen) diluted in PermQuench buffer for 1 hour at room
temperature. Cells were washed with PBS five times and mounted using 5 mL Mowiol.e6 Cell Reports 32, 108008, August 11, 2020
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ware. For structured-illumination super-resolution imaging, specimens were imaged on a GE Healthcare Lifesciences DeltaVision
OMX SR imaging system and images reconstructed using the DeltaVision software. All images were further formatted using FIJI soft-
ware. 3D rendering of image stacks and distance measurements of AIM2-ASC-CASP8 inflammasome specks was performed using
Imaris 8.3.1.
Correlative light and electron microscopy
1.25 3 106 THP-1 cells were seeded in a m-Dish35 mm, high Glass Bottom Grid-500 (81168, ibidi) and differentiated with PMA as
described before. Cells were then pre-stimulated with IFNg overnight and infected with type II (Pru) Tg at an MOI of one for 6 hours.
One hour prior to fixation, 1 mg/mL CellMask Deep Red (H32721, Invitrogen) and 20 mM Hoechst 33342 (H3570, Invitrogen) was
added to the culture medium to label the cells for detection in fluorescence microscopy. Cells were fixed by adding warm 8% (v/
v) formaldehyde (Taab Laboratory Equipment Ltd) in 0.2 M phosphate buffer (PB) pH 7.4 directly to the cell culture medium (1:1)
for 15min. The samples were then washed and imaged in PB using a Zeiss AiryScan LSM 880 confocal microscope. Samples
were then processed using a Pelco BioWave Pro+ microwave (Ted Pella Inc) and following a protocol adapted from the National
Centre for Microscopy and Imaging Research protocol (Deerinck et al., 2010) (See Table S2 for full BioWave program details).
Each step was performed in the Biowave, except for the PB and water wash steps, which consisted of two washes followed by
two washes in the Biowave without vacuum (at 250 W for 40 s). All chemical incubations were performed in the Biowave for
14 min under vacuum in 2 min cycles alternating with/without 100W power. The SteadyTemp plate was set to 21C unless otherwise
stated. In brief, the samples were fixed again in 2.5% (v/v) glutaraldehyde (Taab) / 4% (v/v) formaldehyde in 0.1 M PB. The cells were
then stained with 2% (v/v) osmium tetroxide (Taab) / 1.5% (v/v) potassium ferricyanide (Sigma), incubated in 1% (w/v) thiocarbohy-
drazide (Sigma) with SteadyTemp plate set to 40C, and further stainedwith 2%osmium tetroxide in ddH2O (w/v). The cells were then
incubated in 1% aqueous uranyl acetate (Agar Scientific), and then washed in dH2O with SteadyTemp set to 40
C for both steps.
Samples were then stained with Walton’s lead aspartate with SteadyTemp set to 50C and dehydrated in a graded ethanol series
(70%, 90%, and 100%, twice each), at 250W for 40 s without vacuum. Exchange into Durcupan ACM resin (Sigma) was performed
in 50% resin in ethanol, followed by 4 pure Durcupan steps, at 250 W for 3 min, with vacuum cycling (on/off at 30 s intervals), before
embedding at 60C for 48 h. Blockswere serial sectioned using aUC7 ultramicrotome (LeicaMicrosystems) and 70 nm sectionswere
picked up on Formvar-coated slot copper grids (Gilder Grids Ltd). Consecutive sections were viewed using a 120 kV Tecnai G2 Spirit
transmission electron microscope (Thermo Fischer Scientific) and images were captured using an Orius CCD camera (Gatan Inc).
Individual TEM images of 25-30 consecutive sections per Tg parasite were converted as Tiff in Digital Micrograph (Gatan Inc.)
and aligned using TrakEM2, a plugin of the FIJI framework (Cardona et al., 2012). The stacks were used to check the integrity of
the PV and for coarse alignment with the AiryScan data.
Quantification of protein recruitment to vacuoles and ASC speck formation
Specimens were prepared as described above. Images were acquired using a Ti-E Nikon microscope equipped with LED-illumina-
tion and an Orca-Flash4 camera using a 60xmagnification. All intracellular parasites/bacteria of 100 fields of viewwere automatically
counted based on whether they showed recruitment of the protein of interest using HRMAn high-content image analysis (Fisch et al.,
2019b). Further, the analysis pipeline was used to measure the fluorescence intensity of GBP1 on STm vacuoles using the radial in-
tensity measurement implemented in HRMAn. The coat thickness of decorated vacuoles was determined by calculating the full width
half maximum (FWHM) of the radial intensity measurement following a Gaussian curve fit of the raw fluorescence intensity data dis-
tribution measured starting from the centroid of the respective pathogen vacuole.
For quantification of ASC speck formation, 100 Tg-infected cells were manually counted per condition using a Ti-E Nikon micro-
scope equipped with LED-illumination using 60x magnification based on whether they contain an ASC speck and whether STm was
decorated with GBP1/CASP4. The experiment was repeated independently three times.
Visualization of Tg-DNA release
Type I (RH) Tg were grown in fully confluent and non-replicating HFFs for 3 days in the presence of 20 mM EdU to incorporate the
nucleotide into their DNA. Labeled parasites were then harvested and used for infection as described above. 6 hours p.i. cells
were fixed and EdU incorporated into Tg-DNA visualized by staining the specimens using Click-iT EdU Cell Proliferation Kit for Im-
aging, Alexa Fluor 647 dye (C10340, Invitrogen) according to the manufacturers instruction. Coverslips were further stained with
Hoechst andmounted before imaging on a Ti-E Nikonmicroscope equipped with LED-illumination and an Orca-Flash4 camera using
a 100x magnification.
Vacuole breakage assay - HRMAn
For quantification of Tg or STm vacuole integrity, cells seeded in black-wall 96-well imaging plates were infected and treated as
described before. One hour prior to fixation, 1 mg/mL CellMask Deep Red (H32721, Invitrogen) was added to the culture medium
to load the cytosol of host cells with this fluorescent dye. Following fixation and staining with Hoechst (H3570, Invitrogen), plates
were imaged at 40x magnification on a Cell Insight CX7 High-Content Screening (HCS) Platform (Thermo Scientific) and 25 fields
of view per well were recorded. For STm, plates were imaged at 60x magnification on a confocal Opera Phenix High ContentCell Reports 32, 108008, August 11, 2020 e7
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detected Tg vacuoles or STm was then analyzed using HRMAn (Fisch et al., 2019b). Additionally, HRMAn was used to classify Tg
vacuoles and STm based on recruitment of mCH-GBP1 using the implemented neural network and the dataset stratified into deco-
rated and non-decorated vacuoles or bacteria.
Differential stain for cytosolic STm
To distinguish between STm contained in vacuoles and bacteria that had escaped into the cytosol of infected macrophages, cells
were differentially permeabilized using 25 mg/mL digitonin for oneminute at room temperature as has been described before (Meunier
and Broz, 2015). Cytosolic STmwere then stained using anti-Salmonella antibody (ab35156, Abcam) that has been pre-labeled using
Alexa Fluor 647 Protein Labeling Kit (A20173, Invitrogen) for 15 minutes at 37C, prior to immediate fixation with 4% formaldehyde.
Following fixation cells were permeabilized as described above and all STmwere stained using the same but unlabeled antibody and
corresponding Alexa 488 labeled secondary antibody. Cells were further stained with Hoechst (H3570, Invitrogen) and imaged on a
Leica SP5-inverted confocal microscope using 100x magnification. For quantification, 100 fields of view per coverslip (typically >
1000 individual STm overall) were acquired using a Ti-E Nikon microscope equipped with LED-illumination and an Orca-Flash4 cam-
era at 60x magnification and analyzed with HRMAn (Fisch et al., 2019b) for colocalization of fluorescent signal of all and cytosolic
STm.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data analysis used nested t test, one-way ANOVA or two-way ANOVA. Groups that were compared are indicated in the figure leg-
ends. Benjamini, Krieger and Yekutieli false-discovery rate (Q = 5%) based correction for multiple comparisons as implemented in
Prism was used when making more than 3 comparisons. Graphs were plotted using Prism 8.1.1 (GraphPad Inc.) and presented as
means of n = 3 experiments (with usually 3 technical repeats within each experiment) with error bars representing SEM, unless stated
otherwise. Structure image of GBP1 was created using MacPymol v.1.74 (Schrödinger, Inc.).e8 Cell Reports 32, 108008, August 11, 2020
